As on Thursday, Jasper Therapeutics Inc (NASDAQ: JSPR) got off with the flyer as it spiked 9.08% to $19.83, before settling in for the price of $18.18 at the close. Taking a more long-term approach, JSPR posted a 52-week range of $4.00-$31.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 32.51%. This publicly-traded company’s shares outstanding now amounts to $15.11 million, simultaneously with a float of $11.58 million. The organization now has a market capitalization sitting at $299.63 million. At the time of writing, stock’s 50-day Moving Average stood at $19.00, while the 200-day Moving Average is $20.39.
Jasper Therapeutics Inc (JSPR) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Jasper Therapeutics Inc’s current insider ownership accounts for 23.35%, in contrast to 77.44% institutional ownership. According to the most recent insider trade that took place on Sep 12 ’24, this organization’s Chief Operating Officer sold 900 shares at the rate of 21.23, making the entire transaction reach 19,104 in total value, affecting insider ownership by 25,009.
Jasper Therapeutics Inc (JSPR) Earnings and Revenue Records
Jasper Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 32.51% and is forecasted to reach -4.15 in the upcoming year.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Let’s observe the current performance indicators for Jasper Therapeutics Inc (JSPR). It’s Quick Ratio in the last reported quarter now stands at 10.79. The Stock has managed to achieve an average true range (ATR) of 1.63.
In the same vein, JSPR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.10, a figure that is expected to reach -1.07 in the next quarter, and analysts are predicting that it will be -4.15 at the market close of one year from today.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Through scrutinizing the latest numbers posted by the [Jasper Therapeutics Inc, JSPR], it can be observed that its last 5-days Average volume of 0.68 million was better the volume of 0.16 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 79.51% While, its Average True Range was 1.65.
Raw Stochastic average of Jasper Therapeutics Inc (JSPR) in the period of the previous 100 days is set at 43.58%, which indicates a major fall in contrast to 91.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 84.47% that was higher than 73.45% volatility it exhibited in the past 100-days period.
